|
Adverse effect |
Glucocorticoids |
Cyclosporine |
Tacrolimus |
Azathioprine |
MMF/MPS |
Rapa/Everl |
|
Acne |
2 |
0 |
0 |
0 |
0 |
0 |
|
Alopecia areata |
0 |
0 |
2 |
0 |
0 |
0 |
|
Anemia |
0 |
0 |
0 |
1 |
1 |
2 |
|
Diabetes |
2 |
1 |
3 |
0 |
0 |
1 |
|
Diarrhea |
0 |
1 |
2 |
0 |
3/2 |
1 |
|
Gingival hyperplasia |
0 |
3 |
0 |
0 |
0 |
0 |
|
Hirsutism |
1 |
3 |
0 |
0 |
0 |
0 |
|
HUS/TTP |
0 |
2 |
2 |
0 |
0 |
1 |
|
Hyperlipidemia |
2 |
3 |
1 |
0 |
0 |
3 |
|
Hypertension |
1 |
2 |
1 |
0 |
0 |
0 |
|
Insomnia |
2 |
0 |
0 |
0 |
0 |
0 |
|
Leukopenia |
0 |
0 |
0 |
2 |
2 |
2 |
|
Malignancy |
0 |
1 |
1 |
1 |
0 |
−1 |
|
Neurotoxicity |
2 |
1 |
3 |
0 |
0 |
1 |
|
Obesity |
3 |
0 |
0 |
0 |
0 |
0 |
|
Osteoporosis |
3 |
1 |
1 |
0 |
0 |
0 |
|
Thrombocytopenia |
0 |
0 |
0 |
1 |
2 |
3 |
|
Relationship scale: 0, no relationship with the drug; 1, weak relationship; 2, medium relationship; 3, strong relationship. | ||||||
|
HUS, hemolytic uremic syndrome; MMF, mycophenolate mofetil; MPS, mycophenolate sodium; Rapa/Everl, sirolimus/everolimus; TTP, thrombotic thrombocytopenic purpura. | ||||||